Propofol Patent Expiration
Propofol is Used for preventing microbial growth, administering over a longer period, and inducing anesthesia. It was first introduced by Fresenius Kabi Usa Llc
Propofol Patents
Given below is the list of patents protecting Propofol, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Diprivan |
US8476010 (Pediatric) | Propofol formulations with non-reactive container closures |
Jun 01, 2025
(Expired) | Fresenius Kabi Usa |
| Diprivan | US8476010 | Propofol formulations with non-reactive container closures |
Dec 01, 2024
(Expired) | Fresenius Kabi Usa |
| Diprivan |
US5714520 (Pediatric) | Propofol compostion containing edetate |
Sep 22, 2015
(Expired) | Fresenius Kabi Usa |
| Diprivan |
US5731355 (Pediatric) | Pharmaceutical compositions of propofol and edetate |
Sep 22, 2015
(Expired) | Fresenius Kabi Usa |
| Diprivan |
US5731356 (Pediatric) | Pharmaceutical compositions of propofol and edetate |
Sep 22, 2015
(Expired) | Fresenius Kabi Usa |
| Diprivan |
US5908869 (Pediatric) | Propofol compositions containing edetate |
Sep 22, 2015
(Expired) | Fresenius Kabi Usa |
| Diprivan | US5714520 | Propofol compostion containing edetate |
Mar 22, 2015
(Expired) | Fresenius Kabi Usa |
| Diprivan | US5731355 | Pharmaceutical compositions of propofol and edetate |
Mar 22, 2015
(Expired) | Fresenius Kabi Usa |
| Diprivan | US5731356 | Pharmaceutical compositions of propofol and edetate |
Mar 22, 2015
(Expired) | Fresenius Kabi Usa |
| Diprivan | US5908869 | Propofol compositions containing edetate |
Mar 22, 2015
(Expired) | Fresenius Kabi Usa |
About Veterinary Propofol
Propofol is used in drugs marketed by 3 different companies: Zoetis Inc, Ivaoes Inc Dba Ivaoes Animal Health, Parnell Technologies Pty Ltd.
Other drugs containing Propofol are: Rapanofal , Propoflo, propoflo 28 , Propoclear , Propofolvet multidose .
Veterinary Propofol Patents
Given below is the list of patents protecting Propofol, along with the drug name that holds that patent and the company owning that drug.
| Drug Used In | Drug Patent Number | Drug Patent Expiry | Drug Owner |
|---|---|---|---|
 | |||
| PropoClear | US7550155 | ZOETIS INC. | |
Propofol Petitions
Details of Propofol's suitability petitions are listed below.
| Petitioner | Action | Date of Action | Description |
|---|---|---|---|
 | |||
| Veterinary Research Associates, Inc. | Denied | ||
| IVX Animal Health, Inc. | Denied | ||
Propofol's Family Patents
Explore Our Curated Drug Screens
Clinical Trials
Recent Clinical Trials on Propofol:
Sometimes companies keep conducting clinical trials even after the drug's approval to discover new formulations, methods of use, or new treatment indications, so they could file for additional patents or receive regulatory exclusivity extensions, such as pediatric exclusivity, potentially delaying generic competition. Based on these recent clinical trials, generic companies need to consider the potential for new intellectual property or regulatory hurdles. These strategic moves by the drug owner might delay generic substitution or lead to additional sales of the brand drug, even after patent expiry.
